Loading organizations...
§ Private Profile · San Francisco, CA, USA
AI platform bringing AI algorithms to clinical practice via Carebricks, automating workflows for health systems.
Key people at Bunkerhill Health.
Bunkerhill Health was founded in 2021 by David Eng (Co-Founder) and Nishith Khandwala (Founder).
Based in San Francisco, California, Bunkerhill Health develops artificial intelligence algorithms and the Carebricks platform to integrate clinical reasoning, medical image analysis, and workflow automation directly into electronic health records. The company's technology analyzes patient data, laboratory results, and medical reports to identify actionable clinical findings, enabling generative AI applications that prioritize patient follow-ups and coordinate care across various medical specialties. Operating with a team of 30 employees, the enterprise serves nationwide healthcare systems such as UTMB Health and collaborates with researchers from institutions like Stanford University to validate its models. The organization recently secured multiple 510(k) clearances from the FDA for its proprietary algorithms, including specialized diagnostic tools designed to detect bone mineral density and mitral annular calcification from standard chest CT scans. Bunkerhill Health was founded in 2021 by David Eng and Nishith Khandwala.
Bunkerhill Health was founded in 2021 by David Eng (Co-Founder) and Nishith Khandwala (Founder).
Bunkerhill Health is a healthcare technology company that brings AI algorithms developed by researchers worldwide into clinical practice, enabling health systems to identify at-risk patients and close critical care gaps. Its flagship platform, Carebricks, integrates with electronic health records (EHRs) to analyze structured and unstructured patient data, automate clinical workflows, and recommend next steps without adding workload for clinicians. Bunkerhill serves hospitals and health systems by improving patient outcomes, streamlining care coordination, and boosting operational efficiency through AI-powered clinical reasoning and action[1][2][3].
Founded in 2018, Bunkerhill has rapidly grown by partnering with leading research institutions and health systems, deploying FDA-cleared AI algorithms for early detection of diseases such as heart disease and pancreatic cancer. Its solutions are used by top health systems including UCSF, Mayo Clinic, and Georgetown/MedStar, demonstrating strong growth momentum and adoption in the healthcare AI ecosystem[1][5][7].
Bunkerhill Health was founded in 2018 to bridge the gap between the promise of AI in healthcare and its practical adoption in clinical settings. The company was co-founded by Nishith Khandwala, a former researcher at Stanford’s AIMI center, who recognized that many AI solutions either flagged clinical problems without solving them or were too narrowly focused to scale. Bunkerhill’s idea emerged from the need to create flexible, end-to-end AI workflows that integrate seamlessly with hospital systems and automate actionable clinical steps[1][3][5][6].
Early traction came from building a consortium of over 15 prestigious research institutions (including Stanford, Johns Hopkins, and Harvard) to accelerate AI algorithm development and validation under a shared legal and operational framework. This consortium model significantly reduces the time to launch new AI projects from over a year to just weeks, enabling faster FDA clearance and commercial deployment[5][6][8].
Bunkerhill Health rides the accelerating trend of AI adoption in healthcare, particularly the shift from isolated AI tools to integrated, actionable clinical AI platforms. The timing is critical as health systems face increasing pressure to improve outcomes, reduce costs, and manage complex patient data efficiently. Advances in generative AI, large language models, and FDA regulatory pathways have converged to enable scalable, trustworthy AI solutions embedded in clinical workflows[2][7].
By facilitating multi-institutional collaboration and rapid deployment of validated AI algorithms, Bunkerhill influences the broader ecosystem by lowering barriers for academic researchers to translate innovations into real-world impact. Its approach helps move healthcare AI from experimental pilots to widespread clinical adoption, setting a new standard for AI-driven clinical reasoning and action[5][8].
Looking ahead, Bunkerhill Health is poised to expand its AI platform’s capabilities across more specialties and use cases, leveraging generative AI and continuous learning to further personalize and automate clinical decision-making. The company’s consortium model and regulatory expertise position it well to accelerate the pipeline of FDA-cleared AI tools, driving broader adoption in health systems globally.
Emerging trends such as increased interoperability, AI explainability, and value-based care will shape Bunkerhill’s journey, enhancing its influence as a key enabler of AI-powered healthcare transformation. As clinical AI becomes a standard part of care delivery, Bunkerhill’s vision of activating a "shared brain" across health systems will become increasingly vital to improving patient outcomes and operational efficiency[2][5][7].
Key people at Bunkerhill Health.
